LMP301 2014 Lecture 12.pdf
Premium

6 Pages
114 Views
Unlock Document

Department
Laboratory Medicine and Pathobiology
Course
LMP299Y1
Professor
Kenneth Yip
Semester
Summer

Description
  Lecture  12:  Calcium,  Vitamin  D  &  Parathyroid   Calcium  Fluxes  in  a  Normal  Adult   -­‐ calcium  balanced  is  maintained  by  intake  of  food     -­‐ then  active  exchange  of  intake  through  blood  circulation  and   exchange  between  the  bones   -­‐ some  are  excreted  through  kidney  (c annot  be  absorbed  or   exchanged  by  extracellular  fluid)   -­‐ overall,  intake  =  excretion  balanced  for  healthy  bones     Hormone  Regulation  of   Calcium  Homeostasis   -­‐ parathyroid   hormone  (PTH)   -­‐ 1,25  (OH)  vitD   2 -­‐ calcitonin     Parathyroid  Glands  and  Parathyroid  Hormone  (PTH)   -­‐ PTH  produced  by  parathyroid  glands   -­‐ 4  glands  that  surround  the  thyroid  glands   –  they  produce  PTH     Responses  to  a  Change  of  Serum   [Ca2+]   -­‐ ↓  in  calcium  =  ↑  in  PTH   -­‐ ↑  in  calcium  =  ↓  in  PTH   -­‐ PTH:   o Effect  on  the  bone:  ↑  in  bone  reabsorption   § More  calcium  released  from  bones   § Bones  are  the  largest  storage  of  calcium   o Effect  on  the  kidney:  ↑  in  Ca2+  reabsorption,   ↑  in  1-­‐hydroxylase  and   1,25(OH)2vitD,  ↓  in  phosphate  reabsorption   § Opposite  –  increase  calcium,  decrease   phosphate   § increase  in  1-­‐hydroxylase  in  the  kidney,   and  increase  in   1,25(OH)2vitD       Vitamin  D  and  its  Metabolites   -­‐ humans  get  it  from  precursor  7 -­‐ Dehydrocholesterol  provitamin  D3   -­‐ through  the  skin,  under  UV  stimulation,  we  can   synthesis  Vitamin  D   -­‐ goes  to  the  liver  through  circulation,  the  liver  has   the  enzyme  25-­‐hydroxylase  à  synthesize  25-­‐ hydroxyVitD   -­‐ in  the  kidney,  it  produces  1-­‐alpha-­‐hydroxylase  to   convert  25-­‐OH-­‐D3  to  1,25dihydroxy-­‐VitD   -­‐ 1,25dihydroxy-­‐VitD  is  the  active  hormone   o can  be  further  metabolized  by  24-­‐ hydroxylase  to  become  inactive  and   excreted     -­‐ we  get  out  vitamin  D  through  the  sun,  milk,  fish   -­‐ 1,25dihydroxy-­‐VitD  functions:  regulate  calcium  balance   (homeostasis),  maintain  bone  and  muscle  health,  functions   as  immnomodulators  (to  prevent  immune  disease),   paracrine  and  autocrine  functions   -­‐ endocrine:  hormones  secreted  into  the  blood   -­‐ paracrine  and  autocrines:  affect  nearby/own  cells  to   regulate  function   -­‐ pancreas,  prostate,  breast,  colon   –  all  of  these  tissues       contain  1-­‐hydroxylase  à  they  can  convert  25(OH)D3  to  1,25dihydroxy -­‐VitD  à  these  tissues  can  affect  their  own  cells   and  near  by  cells  (wont  have  overall  circulation  concentration,  but  can  have  a  local  concentration  of  the  hormone  to   regulate  cell  growth)   o patients  with  higher  vitamin  D  levels  =  lower  risk  of  cancer   o vitamin  D  supplements  =  cancer  prevention     1,25  (OH) 2  vitD  –  Hormonal  Effects   -­‐ Effect  on  intestine:     o ↑Ca2+  absorption   o ↑phosphate  absorption   -­‐ Effect  on  bone:     o ↑bone  resorption   -­‐ Effect  on  parathyroid  gland:   o ↓PTH  synthesis  and  secretion   -­‐ Inhibits  its  own  synthesis  and  stimulates  its  metabolism   o If  there  is  enough  1,25 2(OH)  vitD,  it  will  decrease  1-­‐hydroxylase  expression  and  increase  24 -­‐hydrozylase   secretion   o Decrease  synthesis,  increased  metabolism   -­‐ Most  of  the  1,25  2OH)  vitD  is  bound  to  vitamin  D-­‐binding  protein  in  the  circulation  (they  are  steroid  horones)   -­‐ Actions  via  specific  nuclear  vitamin  D  receptor   o binds  gene  response  element   o affects  gene  expression  à  how  VitD  affects  gene  expression     Calcitonin   -­‐ effects  calcium  concentration,  but  in  normal  subjects,  it  is  not  a  major  force  of  hormonal  regulation  of  calcium   -­‐ 32-­‐amino  acid  peptide,  secreted  by  the  parafollicular  or  C  cells  of  thyroid  gland   -­‐ Stimulated  by  high  [Ca2+],  and  GI  hormones  (e.g.  gastrin  and  pentagastrin)   -­‐ Effect  on  serum  [Ca]:  Ca ↓ 4  PO ↓   o its  function  is  usually  not  significant  in  the  regulation  of  normal  calcium  homeostasis   -­‐ Inhibits  bone  resorption  by  osteoclasts     o used  for  treatment  of  postmenopausal  osteoporosis,  Paget’s  disease,  etc.   -­‐ Tumour  marker   o medullary  thyroid  carcinoma  (a  tumour  of  the  C  cells)     Clinical  Significance  of  Calcium   -­‐ Hypocalcemia     o presents  with  neuromuscular  hyperexcitability,  such  as  tetany,  Trousseau’s  sign   o TETANY:  a  syndrome  manifested  by  sharp  flexion  of  the  wrist  and  ankle   joints,  muscle  twitching   and  cramps   -­‐ Hypercalcemia     o presents  with  reduced  neuromuscular  excitability   o causes    fatigue,  weakness,  depression,  inability  to  concentrate   o may  induce  mild  nephrogenic  diabetes  insipidus  with  thirst,  polydipsia  and  polyuria  (ADH  resistance)   § abnormal  potassium  concentration  will  also  cause  ADH  resistance     § here  polydipsia  and  polyuria  is  due  to  hypercalcemia   § renal  stone  from  chronic  hypercalcemia  and  hypercalciuria   • lots  of  calcium  excreted  in  urine     Causes  of  Hypocalcemia   -­‐ Hypoparathyroidism:  idiopathic,  postsurgical     o Parathyroid  glands  fail  to  produce  PTH   -­‐ Pseudohypoparathyroidism  (PTH  resistance)     o PTH  receptor  deficiency  or  defect   o Receptor  cannot  response  to  PTH   o But  feedback  will  increase  PTH  express,  but  no  downstream   response   o Patient  will  have  hypothyroidism  with  high  PTH  levels   o PTH  level  is  high,  low  calcium   -­‐ Magnesium  deficiency     o Magnesium  influences  the  secretion  of  PTH  (PTH  relies  on  magnesium)       o Severe  hypomagnesemia  may  cause  hypoparathyroidism   § Deficiency  in  magnesium  =  parathyroid  gland  cannot  secrete  PTH   § In  order  to  treat  this  type  of  hypocalcaemia,  have  t  give  magnesium     -­‐ Renal  failure     o Can  cause  hypocalcaemia  à  renal  disease  causes  renal  tissue  to  have  problems  in  producing  1 -­‐ hydroxylase  and  failure  in  excreting  p hosphate   o due  to  phosphate  retention  and  1,25(OH)2 vitD  deficiency   -­‐ Vitamin  D  deficiency  –  causes  hypocalcaemia:     o dietary     o lack  of  sun  exposure   o malabsorption  (cannot  efficiency  absorb  from  diet)   o chronic  liver  disease  –  liver  cells  cannot  convert  vitamin  D  into 21,25  (OH)  vitD  =  vitamin  D  deficiency       o chronic  renal  disease   o vitamin-­‐D  dependent  rickets  –  causes  hypocalcaemia  as  well     What  are  the  Calcium  and  PTH  levels  in  Renal  Failure  and  Vitamin  D    ciency? -­‐ low  calcium,  high  PTH   What  are  the  causes  of  Secondary  Hyperparathyroidism?   -­‐ renal  failure  and  vitamin  D  deficiency  can  cause  secondary  hyperparathyroidism     o secondary:  causes  outside  the  parathyroid  glands   o these  causes  are  outside  –  nothing  to  do  with  parathyr oid  gland   o parathyroid  gland  is  healthy,  respond  to  low  calcium  to  increase  PTH  secretion   -­‐ over  secretion  of  PTH  by  the  parathyroid  glands  =  primary  hyperparathyroidism       Causes  of  Hypercalcemia   -­‐ Mechanisms:     o Increased  intestinal  absorption:  e.g.  Vit  D  intoxication   o Enhanced  renal  retention  of  calcium   o Increased  bone  resorption:  e.g.  immobilization   o combination  of  above   -­‐ Primary  hyperparathyroidism     -­‐ Malignancies:  cancer  with  or  w/o  bone  metastases  (e.g.  PTHrP)   o Some  cancer  cells  can  produce  PTHrP  (parathyroid  hormone  related  peptide)   à  peptide  is  produced  by  a   different  gene  (not  the  PTH  gene)   o But  this  peptide  shares  the  same  N -­‐terminal  as  PTH  =  can  bind  to  PTH  receptors  to  mimic  PTH  function   à   increase  calcium  resorption  from  the  kidney  and  incre ase  phosphate  excretion   o But  this  peptide  CANNOT  increase  1-­‐hydroxylse  expression  à  no  increase  of  1,25  (OH)  vitD   2 o Patients  with  abonormally  high  PTHrP:  hypercalcemia  and  low  phosphate   o This  hormone  is  also  expressed  on  normal  tissues,  not  only  on  tumors à  but  expression  is  much  higher  in   tumors  à  enough  to  cause  hypercalemia     • Derived  from  a  gene  on  chromosome  12,   distinct  from  PTH  gene  on  chromosome  11   • N-­‐terminal  end  showing  close  homology  to  PTH  (8  of  the  first  13  amino  acids),  the  remainder  with  little   homology   • Binding  to  PTH  receptor,  mimi cking  biological  actions  of  PTH   • PTH
More Less

Related notes for LMP299Y1

Log In


OR

Join OneClass

Access over 10 million pages of study
documents for 1.3 million courses.

Sign up

Join to view


OR

By registering, I agree to the Terms and Privacy Policies
Already have an account?
Just a few more details

So we can recommend you notes for your school.

Reset Password

Please enter below the email address you registered with and we will send you a link to reset your password.

Add your courses

Get notes from the top students in your class.


Submit